Albertsons Companies and Walmart Donate Their Dispensing Services to HHS to Support the Ending the HIV Epidemic Initiative | HIV.gov

Albertsons Companies and Walmart Donate Their Dispensing Services to HHS to Support the Ending the HIV Epidemic Initiative | HIV.gov

Albertsons Companies and Walmart Donate Their Dispensing Services to HHS to Support the Ending the HIV Epidemic Initiative The U.S. Department of Health & Human Services (HHS) will further expand access to pre-exposure prophylaxis (PrEP) HIV prevention medications by adding donated dispensing services from Albertsons Companies and Walmart to the Ready, Set, PrEP program beginning no later than July 30, 2020. The program allows uninsured patients to fill their prescriptions at no cost. LEARN MORE

FDA Approves New Drug to Treat Infants and Children with HIV On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments. LEARN MORE